OKYO Pharma
(LSE) OKYO
This security has been delisted. This page is retained for historical reference.
OKYO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowOKYO Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
1%
Return on Capital
2%
Return on Assets
-99%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$2.56K
Operating Income
$7.19M
EBITDA
$7.08M
Operating Cash Flow
$4.16M
Capital Expenditure
$1.27K
Free Cash Flow
$4.16M
Cash & ST Invst.
$1.56M
Total Debt
$0.00
OKYO Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$0.00
N/A
Gross Profit
$1.44K
+63.4%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
7
N/A
Net Income
$4.70M
-60335.8%
EBITDA
$7.08M
-91900.3%
Quarterly Fundamentals
Net Cash
$1.56M
-14.7%
Accounts Receivable
$1.89M
+92.7%
Inventory
$0.00
-100.0%
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
-99.34%
N/A
Return on Invested Capital
2.04%
N/A
Free Cash Flow
$717.26K
-87.9%
Operating Cash Flow
$712.23K
-86.7%